Abeona Therapeutics Stock Widgets and Gadgets
| ABEO Stock | USD 4.97 0.07 1.39% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- ABEO Abeona Therapeutics
- Latest Trend Tracker for - Stock Traders Daily
- ABEO 4.97 -0.07
- Low 4.85
- High 5.14
- Alpha -0.14
- Beta 0.71
- Return On Equity -2.17
- Return On Asset -0.46
- Current Valuation 166.54 M
- Shares Outstanding 48.53 M
- Shares Owned By Insiders 4.80 %
- Shares Owned By Institutions 68.51 %
- Number Of Shares Shorted 2.39 M
- Price To Earning 0.11 X
- Price To Book 5.48 X
- Price To Sales 37.76 X
- Gross Profit (34.36 M)
- EBITDA (64.21 M)
- Net Income (63.73 M)
- Cash And Equivalents 20.1 M
- Cash Per Share 3.38 X
- Total Debt 23.05 M
- Debt To Equity 0.42 %
- Current Ratio 2.21 X
- Book Value Per Share 0.96 X
- Cash Flow From Operations (56.02 M)
- Short Ratio 7.19 X
- Earnings Per Share (1.55) X
- Target Price 16.75
- Number Of Employees 136
- Beta 1.78
- Market Capitalization 241.21 M
- Total Asset 108.93 M
- Retained Earnings (813.26 M)
- Working Capital 84.27 M
- Current Asset 31.95 M
- Current Liabilities 6.51 M
- Net Asset 108.93 M
- Accumulation Distribution 0.0564
- Daily Balance Of Power (0.24)
- Rate Of Daily Change 0.99
- Day Median Price 4.99
- Day Typical Price 4.99
- Market Facilitation Index 0.29
- Price Action Indicator (0.06)
- Period Momentum Indicator (0.07)
- Relative Strength Index 44.86
Market Snapshot Widget Example
DAX Index Germany | 22,462 0.96 | |
Taiwan Weighted Taiwan | 21,603 1.59 | |
PSI 20 Stock Portugal | 6,951 0.75 | |
CROBEX Croatia | 3,329 0.11 | |
Budapest SE Hungary | 91,416 1.41 | |
IDX 30 Jakarta Indonesia | 386.86 0.42 | |
ISEQ 20 Price Ireland | 1,760 1.45 | |
NYSE Comp USA | 19,270 1.35 | |
Tel Aviv 35 Israel | 2,461 0.89 | |
Coreshares Index Tracker South Afric | 1,108 1.95 | |
IPC MEXICO Mexico | 53,173 0.57 | |
KL Technology Malaysia | 50.27 1.32 | |
IBEX 35 Index Spain | 13,309 0.84 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 4,176 2.08 | |
SPASX Dividend Opportunities Australia | 1,661 0.80 | |
HNX 30 Vietnam | 502.01 1.15 | |
Bucharest BET-NG Romania | 1,262 0.07 | |
AMS Small Cap Netherlands | 1,381 0.78 | |
Oslo Exchange Mutual Norway | 1,463 1.34 | |
BEL Small Belgium | 8,418 0.15 | |
Basic Materials Brazil | 5,422 1.55 | |
Swiss Leader Price Switzerland | 2,074 0.42 | |
Fondo Mutuo ETF Chile | 1,563 0.48 | |
Athens General Comp Greece | 1,736 0.6 | |
Stock Exchange Of Thailand | 1,175 1.05 | |
PX Prague Stock Czech Repub | 2,119 1.22 | |
THE PHILIPPINE STOCK Philippines | 6,147 0.13 | |
WIG 30 Poland | 3,505 1.04 | |
BIST Electricity Turkey | 465.96 1.39 |
Investing Ideas
In addition to having Abeona Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Abeona Therapeutics
Compare Abeona Therapeutics To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.